99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast Cancer With Metastatic Lymph Nodes Before Targeted Therapy
Clinical trial NCT05695859 · COMPLETED
Trial details
- NCT number
- NCT05695859
- Sponsor
- Tomsk National Research Medical Center of the Russian Academy of Sciences
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-20
- Primary completion
- 2023-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.